tiprankstipranks
Trending News
More News >
Akums Drugs and Pharmaceuticals Limited (IN:AKUMS)
:AKUMS
India Market

Akums Drugs and Pharmaceuticals Limited (AKUMS) Stock Forecast & Price Target

Compare
4 Followers
See the Price Targets and Ratings of:

AKUMS Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Akums
Drugs and Pharmaceuticals Limited
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

AKUMS Stock 12 Month Forecast

There Are No Analyst Ratings for IN:AKUMS In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

AKUMS Financial Forecast

AKUMS Earnings Forecast

The previous quarter’s earnings for AKUMS were ₹2.60.
The previous quarter’s earnings for AKUMS were ₹2.60.

AKUMS Sales Forecast

The previous quarter’s earnings for AKUMS were ₹10.18B.
The previous quarter’s earnings for AKUMS were ₹10.18B.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
ICICI Securities Analyst forecast on IN:AKUMS
ICICI Securities
ICICI Securities
₹710₹655
Buy
55.92%
Upside
Reiterated
08/12/25
ICICI Securities Sticks to Their Buy Rating for Akums Drugs and Pharmaceuticals Limited (AKUMS)
Citi
₹700
Buy
66.63%
Upside
Initiated
03/12/25
Citi Starts Akums Drugs #x26; Pharmaceuticals (AKUMS:IN) at BuyCiti analyst Vivek Agrawal initiates coverage on Akums Drugs Pharmaceuticals (AKUMS:IN) with a Buy rating and a price target of INR700.00.
Ambit Holdings Analyst forecast on IN:AKUMS
Ambit Holdings
Ambit Holdings
₹840
Buy
99.95%
Upside
Initiated
01/07/25
Ambit Capital Starts Akums Drugs #x26; Pharmaceuticals (AKUMS:IN) at Buy (1)Ambit Capital analyst Prashant Nair initiates coverage on Akums Drugs Pharmaceuticals (AKUMS:IN) with a Buy (1) rating and a price target of INR840.00.
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
ICICI Securities Analyst forecast on IN:AKUMS
ICICI Securities
ICICI Securities
₹710₹655
Buy
55.92%
Upside
Reiterated
08/12/25
ICICI Securities Sticks to Their Buy Rating for Akums Drugs and Pharmaceuticals Limited (AKUMS)
Citi
₹700
Buy
66.63%
Upside
Initiated
03/12/25
Citi Starts Akums Drugs #x26; Pharmaceuticals (AKUMS:IN) at BuyCiti analyst Vivek Agrawal initiates coverage on Akums Drugs Pharmaceuticals (AKUMS:IN) with a Buy rating and a price target of INR700.00.
Ambit Holdings Analyst forecast on IN:AKUMS
Ambit Holdings
Ambit Holdings
₹840
Buy
99.95%
Upside
Initiated
01/07/25
Ambit Capital Starts Akums Drugs #x26; Pharmaceuticals (AKUMS:IN) at Buy (1)Ambit Capital analyst Prashant Nair initiates coverage on Akums Drugs Pharmaceuticals (AKUMS:IN) with a Buy (1) rating and a price target of INR840.00.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Akums Drugs and Pharmaceuticals Limited

1 Month
xxx
Success Rate
0/2 ratings generated profit
0%
Average Return
-12.35%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 0.00% of your transactions generating a profit, with an average return of -12.35% per trade.
3 Months
xxx
Success Rate
0/2 ratings generated profit
0%
Average Return
-12.75%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -12.75% per trade.
1 Year
Abdulkader PuranwalaICICI Securities
Success Rate
0/2 ratings generated profit
0%
Average Return
-21.40%
reiterated a buy rating 5 months ago
Copying Abdulkader Puranwala's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -21.40% per trade.
2 Years
xxx
Success Rate
0/2 ratings generated profit
0%
Average Return
-21.40%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -21.40% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

AKUMS Analyst Recommendation Trends

Rating
Aug 25
Sep 25
Oct 25
Nov 25
Dec 25
Strong Buy
0
0
0
0
0
Buy
1
1
1
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
1
1
1
0
0
In the current month, AKUMS has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. AKUMS average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

AKUMS Stock Forecast FAQ

What is IN:AKUMS’s average 12-month price target, according to analysts?
Currently, no data Available
What is IN:AKUMS’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for IN:AKUMS, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Akums Drugs and Pharmaceuticals Limited a Buy, Sell or Hold?
      Currently, no data Available
      What is Akums Drugs and Pharmaceuticals Limited’s share price target?
      Currently, no data Available
      What do analysts say about Akums Drugs and Pharmaceuticals Limited?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Akums Drugs and Pharmaceuticals Limited?
      To buy shares of IN:AKUMS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.